Published in Br J Anaesth on April 01, 1982
Electro-acupuncture in relieving labor pain. Evid Based Complement Alternat Med (2006) 1.15
Plasma beta-endorphin levels in oral surgery patients following diazepam, fentanyl or placebo. Anesth Prog (1984) 0.75
A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J (2000) 3.40
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res (1969) 2.63
Analysis of long-chain free fatty acid binding to bovine serum albumin by determination of stepwise equilibrium constants. Biochemistry (1971) 2.33
Pencil-point needles and combined spinal epidural block. Why needle through needle? Anaesthesia (1998) 2.17
Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors. Cancer Res (1989) 2.04
Isoflurane in labour. Anaesthesia (1993) 2.02
Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia (1997) 1.99
Cold curing acrylic bone cement. A clinical study of the cardiovascular side effects during hip joint replacement. Anaesthesia (1971) 1.90
A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J Nucl Med (1990) 1.85
A method for comparing the potencies of -aminobutyric acid antagonists on single cortical neurones using micro-iontophoretic techniques. Br J Pharmacol (1973) 1.82
Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology (1999) 1.60
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology (1999) 1.48
A comparative study of some convulsant substances as gamma-aminobutyric acid antagonists in the feline cerebral cortex. Br J Pharmacol (1973) 1.45
Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. Anesthesiology (1990) 1.44
Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene. Anesthesiology (1995) 1.44
Comparison of automatic oscillometric arterial pressure measurement with conventional auscultatory measurement in the labour ward. Br J Anaesth (1993) 1.42
Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group. Anesthesiology (1990) 1.42
Capnography and awareness. Anaesthesia (1992) 1.41
Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem (1995) 1.40
Overpressure isoflurane at caesarean section: a study of arterial isoflurane concentrations. Br J Anaesth (1994) 1.40
Molecular genetics and malignant hyperthermia. Anesthesiology (1991) 1.39
A technique allowing e.e.g. and activity recording together with intraventricular administration of drugs in the conscious rabbit. Br J Pharmacol (1973) 1.39
A re-evaluation of the Whitacre spinal needle in obstetric anaesthesia--a pilot study. Anaesthesia (1990) 1.39
Endogenous opioids and pain: a review. J R Soc Med (1981) 1.38
Bicyclic phosphorus esters that are potent convulsants and GABA antagonists. Nature (1976) 1.37
Antagonism of GABA by picrotoxin in the feline cerebral cortex. Br J Pharmacol (1972) 1.37
Influence of free fatty acid concentration on drug binding to plasma albumin. Ann N Y Acad Sci (1973) 1.37
Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther (1995) 1.37
Long chain fatty acid binding to human plasma albumin. J Biol Chem (1975) 1.36
Evaluation of bicuculline as a GABA antagonist. Nature (1971) 1.35
Evidence that bicuculline can both potentiate and antagonize GABA. Br J Pharmacol (1971) 1.34
Convulsive properties of d-tubocurarine and cortical inhibition. Nature (1972) 1.25
Rat hippocampal slices 'in vitro' display spontaneous epileptiform activity following long-term organotypic culture. J Neurosci Methods (1989) 1.24
kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br J Pharmacol (1988) 1.23
Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus. Br J Pharmacol (1988) 1.19
Effects of a focal penicillin lesion on responses of rabbit cortical neurones to putative neurotransmitters. Br J Pharmacol (1972) 1.19
Simulation of resistance forces acting on surgical needles. Proc Inst Mech Eng H (1997) 1.17
On facilitated oxygen diffusion in muscle tissues. Biophys J (1980) 1.16
Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs. Can J Physiol Pharmacol (1997) 1.16
Neurotransmitter candidates of somatosensory primary afferent fibres. Neuroscience (1983) 1.15
Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia (1997) 1.15
Fracture toughness of acrylic denture base. Biomaterials (1983) 1.13
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology (1996) 1.12
Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies. Cephalalgia (1997) 1.12
Analysis of macromolecule--ligand binding by determination of stepwise equilibrium constants. Biochemistry (1970) 1.10
The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol (1993) 1.10
Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology (1997) 1.08
Crystallization modifies osteoconductivity in an apatite-mullite glass-ceramic. J Mater Sci Mater Med (2003) 1.08
Cardiovascular changes during laparoscopy. Studies of stroke volume and cardiac output using impedance cardiography. Anaesthesia (1976) 1.06
Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet (2001) 1.05
Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics (1992) 1.05
Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology (1995) 1.05
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology (2000) 1.04
Lysine 49 phospholipase A2 proteins. Toxicon (1999) 1.03
Medium chain fatty acid binding to human plasma albumin. J Biol Chem (1972) 1.02
Proceedings: Presynaptic inhibition and the depressant actions of GABA and glycine in the feline cuneate nucleus: changes related to electrographic seizure activity. J Physiol (1973) 1.02
Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2. Toxicon (1981) 1.02
The binding of palmitoyl-CoA to bovine serum albumin. Biochim Biophys Acta (1990) 1.02
Second stage of labour with or without extradural analgesia. Anaesthesia (1983) 1.02
Pulmonary and cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing titanium dioxide nanoparticles. Inhal Toxicol (2012) 1.02
Randomized study of intravenous fluid preload before epidural analgesia during labour. Br J Anaesth (2000) 1.01
Plus and minus-bicuculline methochloride as optical isomers of a GABA antagonist. Nature (1974) 1.01
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur J Pharmacol (1997) 1.01
Amino acid antagonists and the depression of cuneate neurones by -aminobutyric acid (GABA) and glycine. Br J Pharmacol (1973) 1.01
Microiontophoretic release of drugs from micropipettes: use of 24Na as a model. Br J Pharmacol (1973) 1.01
Posture and post-spinal headache. A controlled trial in 80 obstetric patients. Br J Anaesth (1988) 1.01
Actions of the GABAB agonist, (-)-baclofen, on neurones in deep dorsal horn of the rat spinal cord in vitro. Br J Pharmacol (1989) 1.00
Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics (1991) 1.00
Antagonism of gamma-aminobutyric acid and glycine by convulsants in the cuneate nucleus of cat. Br J Pharmacol (1976) 1.00
Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur J Neurosci (2001) 1.00
Excitation of single sensory neurones in the rat caudal trigeminal nucleus by iontophoretically applied adenosine 5'-triphosphate. Neurosci Lett (1983) 1.00
A preliminary comparison of the mechanical properties of chemically cured and ultrasonically cured glass ionomer cements, using nano-indentation techniques. Biomaterials (2001) 1.00
Influence of sodium oxide content on bioactive glass properties. J Mater Sci Mater Med (1999) 1.00
Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain (1997) 0.99
Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994. Neuropharmacology (1994) 0.99
Antagonism by folic acid of presynaptic inhibition in the rat cuneate nucleus. Br J Pharmacol (1974) 0.99
Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo. Toxicon (1993) 0.99
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol (1999) 0.99
Pharmacological profile of PD 117302, a selective kappa-opioid agonist. Br J Pharmacol (1987) 0.98
The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br J Pharmacol (1988) 0.98
In vivo evidence for spinal delta-opiate receptor operated antinociception. Neuropeptides (1986) 0.97
Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses. Cephalalgia (1998) 0.97
L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. Eur J Pharmacol (1996) 0.96
Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol (1997) 0.96
Role of the prenyl group on the G protein gamma subunit in coupling trimeric G proteins to A1 adenosine receptors. J Biol Chem (1996) 0.96
PD117302: a selective agonist for the kappa-opioid receptor. Br J Pharmacol (1988) 0.96
Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. Br J Pharmacol (1992) 0.96
A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors. Abacavir CNA2007 International Study Group. J Acquir Immune Defic Syndr (1999) 0.95
Fiberoptic-guided endotracheal intubation via the laryngeal mask airway in pediatric patients: a report of a series of cases. Anesth Analg (1996) 0.95
The effect of phosphate content on the bioactivity of soda-lime-phosphosilicate glasses. J Mater Sci Mater Med (2009) 0.95
Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br J Pharmacol (2001) 0.94
Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol (1999) 0.94
Proceedings: Some neuropharmacological properties of the new non-barbiturate hypnotic etomidate (R (+)-ethyl-1-(alpha-methyl-benzyl) imidazole-5-carboxylate). Br J Pharmacol (1975) 0.94
Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat. Br J Pharmacol (1993) 0.94
Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience (2003) 0.93
Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. Br J Pharmacol (1993) 0.93
Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro. Neuroscience (1987) 0.93
Termination of pregnancy with Utus paste: report of a fatal case. Br Med J (1975) 0.93